Re: Farmas USA
AGEN
Publicación de resultados financieros.... -0,38$ cuando se esperaba -0,33....15,7M$ cuando se esperaban 5,4M$....
- Enrollment of CTLA-4 & PD-1 trials on track; data expected 2H2019
- Second generation CTLA-4 advances in clinic; data expected 2H2019
- Launched commercial readiness with head of commercial on board
- $15M in cash milestones triggered; new compounds move towards clinic
- GSK's Shingrix sales continue to grow; projected to be ~$1.3Bn in 2019
https://agenusbio.com/wp-content/uploads/2019/08/AGENUS_News_Vol2_Issue13_V4.pdf
https://investor.agenusbio.com/2019-08-08-Agenus-Milestone-Triggers-7-5M-Payment
Vamos a ver qué pasa hoy, pero parece que de aquí a final de año, puede ser movidito...
Un saludo